MedPath

Music Therapy in Acute Leukemia Patients With Fatigue

Not Applicable
Not yet recruiting
Conditions
Acute Myeloid Leukemia
Fatigue
Interventions
Other: Music Therapy
Registration Number
NCT06286332
Lead Sponsor
Chang Gung University
Brief Summary

The objective of this study is to assess the efficacy of employing music therapy in alleviating fatigue and medical laboratory values among patients with acute myeloid leukemia.

Detailed Description

The researchers will explain the study objectives and methods, obtain informed consent, and have participants sign the consent form before commencing the study. Participants are randomly assigned to Group A and Group B. Participants in Group A undergo 30 minutes of self-selected music playback every day in addition to receiving standard therapy, while participants in Group B only receive standard therapy. The entire study duration spans 21 days.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Diagnosed with acute myeloid leukemia by a clinical specialist.
  2. Patients undergoing chemotherapy for the first time.
  3. Aged 18 years or older, capable of communicating in Mandarin or Taiwanese.
  4. Normal hearing ability.
  5. No history of psychiatric disorders and clear consciousness.
  6. Participants with no prior involvement in any intervention studies related to fatigue management.
  7. Demonstrates understanding of the research objectives, willingly participates in the study, and completes the informed consent form.
  8. Willing to cooperate with study procedures throughout the research period.
Exclusion Criteria
  1. Severe hearing impairment.
  2. Individuals with unstable vital signs or altered consciousness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Music TherapyMusic TherapyParticipants received self-selected music app playback for 30 minutes every day and standard therapy. The entire study duration spans 21 days.
Primary Outcome Measures
NameTimeMethod
Change from baseline in fatigue on the Tang Fatigue Rating Scale (TFRS) and 11-point Numeric Rating Scale (NRS-11) at day 21.Baseline and Day 21.

The TFRS and NRS-11 is validated, self-reported instrument assessing average fatigue intensify.

The TFRS comprises a total of 37 items, encompassing 15 questions related to physiological aspects, 12 questions addressing psychosocial factors, and 10 questions focusing on daily living activities. The scoring system ranges from 1 to 10, with higher scores indicating a greater level of fatigue.

NRS-11 scores range from 0 (no fatigue) to 10 (worst possible fatigue). Change = (Day 21 score - Baseline score).

Secondary Outcome Measures
NameTimeMethod
Change from baseline in neutrophil, hemoglobin, abumin at day 21.Baseline and Day 21.

The alterations in hematologic parameters, specifically white blood cell count, hemoglobin levels, and albumin levels, were assessed through blood samples collected at baseline and on the 21st day.

© Copyright 2025. All Rights Reserved by MedPath